They exist at the borders of tumors and exhibit prolonged interactions with tumor-specific CD8+ T cells, yet they frequently fail to stimulate the T cells to mediate an antitumor effect (Engelhardt et al., 2012; Boissonnas et al., 2013; Broz et al., 2014). The gene discussed is CD8A; the disease is neoplasm.